SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-056813
Filing Date
2015-06-26
Accepted
2015-06-26 16:15:42
Documents
2
Period of Report
2015-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4145
2 EX-24 DOCUMENT attachment1.htm EX-24 4332
  Complete submission text file 0001209191-15-056813.txt   10057
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Perkins Adelene Q (Reporting) CIK: 0001375124 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 15955298